Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular profile of catabolic versus anabolic treatment regimens of parathyroid hormone (PTH) in rat bone: An analysis by DNA microarray

18 Mar 2005

Abstract excerpt

Teriparatide, human PTH (1-34), a new therapy for osteoporosis, elicits markedly different skeletal responses depending on the treatment regimen. In order to understand potential mechanisms for this dichotomy, the present investigation utilized microarrays to delineate the genes and pathways that are regulated by intermittent (subcutaneous injection of 80 microg/kg/day) and continuous (subcutaneous infusion of 40...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bone health and osteoporosis research
Share to Bone health and treatments
Share to Bone Metabolism and Diseases

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 15779007
DOI: 10.1002/jcb.20438

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular profile of catabolic versus anabolic treatment regimens of parathyroid hormone (PTH) in rat bone: An analysis by DNA microarrayPMID 15779007Read ↗

Determination of Dual Effects of Parathyroid Hormone on Skeletal Gene Expression in Vivo by Microarray and Network AnalysisSemantic proximity Read ↗

Catabolic effects of continuous human PTH (1--38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation.Semantic proximity Read ↗

Altered extracellular matrix and mechanotransduction gene expression in rat bone tissue following long-term estrogen deficiencySemantic proximity Read ↗

MicroRNA levels in bone and blood change during bisphosphonate and teriparatide therapy in an animal model of postmenopausal osteoporosisSemantic proximity Read ↗

Gene Expression Profiles and Transcription Factors Involved in Parathyroid Hormone Signaling in Osteoblasts Revealed by Microarray and BioinformaticsSemantic proximity Read ↗

Longitudinal Changes of Circulating miRNAs During Bisphosphonate and Teriparatide Treatment in an Animal Model of Postmenopausal OsteoporosisSemantic proximity Read ↗

Gene expression patterns in bone following mechanical loadingSemantic proximity Read ↗

Teriparatide (1-34 human PTH) regulation of osterix during fracture repair.Semantic proximity Read ↗

Different gene expression patterns in the bone tissue of aging postmenopausal osteoporotic and non-osteoporotic women.Semantic proximity Read ↗

Temporal Gene Expression Profiling during Rat Femoral Marrow Ablation-Induced Intramembranous Bone RegenerationSemantic proximity Read ↗

Abnormal muscle and hematopoietic gene expression may be important for clinical morbidity in primary hyperparathyroidismSemantic proximity Read ↗

PTH-Induced Behavioral and Metabolic Alterations in Mouse Models of HyperparathyroidismSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.